Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.44 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.44 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.38 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.38 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.38 |
| ▸ | ECE1 | P42892 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9225749 | 0.97 | PTGS1 (0.44) | PTGS1GSTK1GLO1OPRM1OPRD1 | |
| SCHEMBL17479582 | 0.97 | PTGS1 (0.46) | PTGS1GSTK1GLO1OPRM1OPRD1 | |
| SCHEMBL8503980 | 0.97 | PTGS1 (0.46) | PTGS1GSTK1GLO1OPRM1OPRD1 | |
| SCHEMBL8014827 | 0.97 | PTGS1 (0.46) | PTGS1GSTK1GLO1OPRM1OPRD1 | |
| SCHEMBL2169172 | 0.97 | PTGS1 (0.46) | PTGS1GSTK1GLO1OPRM1OPRD1 | |
| SCHEMBL6129324 | 0.97 | PTGS1 (0.46) | PTGS1GSTK1GLO1OPRM1OPRD1 | |
| SCHEMBL1442864 | 0.97 | PTGS1 (0.46) | PTGS1GSTK1GLO1OPRM1OPRD1 | |
| SCHEMBL1443581 | 0.97 | PTGS1 (0.46) | PTGS1GSTK1GLO1OPRM1OPRD1 | |
| SCHEMBL8431345 | 0.96 | PTGS1 (0.45) | PTGS1GSTK1GLO1OPRM1OPRD1 | |
| SCHEMBL8135287 | 0.96 | PTGS1 (0.45) | PTGS1GSTK1GLO1OPRM1OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111479558-A | Integrated vaccine design for symbiotic disease progression | 纽约州立大学研究基金会 | 2020-07-31 | — | — | CN | disclosed |
| CN-101293922-A | Streptococcus pneumoniae proteins and nucleic acid molecules | SANOFI PASTEUR LTD (CA) | 2008-10-29 | — | — | CN | disclosed |
| CN-101293921-A | Streptococcus pneumoniae proteins and nucleic acid molecules | SANOFI PASTEUR LTD (CA) | 2008-10-29 | — | — | CN | disclosed |
| CN-101230098-A | Streptococcus pneumoniae proteins and nucleic acid molecules | SANOFI PASTEUR LTD (CA) | 2008-07-30 | — | — | CN | disclosed |
| CN-101230099-A | Streptococcus pneumoniae proteins and nucleic acid molecules | SANOFI PASTEUR LTD (CA) | 2008-07-30 | — | — | CN | disclosed |
| CN-101163720-A | Rodent pest control | SYNGENTA LTD (GB) | 2008-04-16 | — | — | CN | disclosed |
| EP-0721506-A1 | BACTERIAL EXPORTED PROTEINS AND ACELLULAR VACCINES BASED THEREON | THE ROCKEFELLER UNIVERSITY (US) | 1996-07-17 | — | — | EP | disclosed |
| WO-1995006732-A2 | BACTERIAL EXPORTED PROTEINS AND ACELLULAR VACCINES BASED THEREON | THE ROCKEFELLER UNIVERSITY (US) | 1995-03-09 | — | — | WO | disclosed |